Botanical species · safety record

Lycopus europaeus

The EFSA Compendium of Botanicals holds 7 constituent measurements and 1 adverse-effect record for Lycopus europaeus. This page reports what those source records contain and how to reach them. It carries no effect estimate, no dose and no recommendation.

Accepted name in source: Lycopus europaeus L.

7Constituent measurements

1Safety records

4Cited sources

0Licensed products (Canada)

Also recorded as

Lycopus mollis A.Kern.
Lycopus menthifolius Mabille

Synonyms are carried from the source compendium. A species may be traded and studied under more than one name, which is exactly how a safety record gets lost.

Regulatory presence

No Health Canada licensed natural health product in the snapshot names this species as a medicinal ingredient under this exact binomial. Absence here means absence from this one register under this one name, not absence from trade, and not a safety verdict.

What the records describe

Constituents measured

Plant parts

Preparations

Effect types

Target tissues

Recorded constituents

What analytical work has found in this species, at which plant part and preparation. A measured constituent is a fact about material, not about effect.

Substance	Plant part	Preparation	Concentration	Analytical method	Source
3,4-dihydroxybenzoic acid	Unspecified	Solvent extraction	—	Gelpermeation, High Performance Thin Layer Chromatography (HPTLC)	Resolve DOI
4-hydroxybenzoic acid	Unspecified	Solvent extraction	—	Gelpermeation, High Performance Thin Layer Chromatography (HPTLC)	Resolve DOI
P-coumaric acid	Unspecified	Solvent extraction	—	Gelpermeation, High Performance Thin Layer Chromatography (HPTLC)	Resolve DOI
4-hydroxybenzoic acid	Unspecified	Solvent extraction	—	Gelpermeation, High Performance Thin Layer Chromatography (HPTLC)	No resolvable identifier
Coumarins	Unspecified	Solvent extraction	—	Gelpermeation, High Performance Thin Layer Chromatography (HPTLC)	No resolvable identifier
Coumarins	Aerial part of plants	—	0.12 Percent	Phytochemical screening	No resolvable identifier
P-coumaric acid	Unspecified	Solvent extraction	—	Gelpermeation, High Performance Thin Layer Chromatography (HPTLC)	No resolvable identifier

Recorded adverse effects

Adverse effects reported in the source literature, most often in animal or laboratory models at a stated preparation and dose.

Effect	Target tissue	Plant part	Preparation	Test organism	Test type	Source
Endocrine	Glandular: thyroid	Unspecified	Solvent extraction	Rat (as animal)	Not reported	Resolve DOI

Cited sources

The literature the compendium cites for this species. Metatron Health has no relationship with these authors or journals and earns nothing from citing them.

Swiatek, L., Grabias, B., Rozga, M. Phenolic acids and coumarins in Lithospermum arvense L. and Lycopus europaeus L. Herba polonica, 1987, vol. 33, no. 2, p. 87-97.
Sharipov, Sh. N., Goryaev, M. I., Khazanovich, R. L., Pulatova, T. P., Sharipova, F. S. Essential oil from Lycopus europaeus. Khimiya prirodnykh soedinenii, 1969, vol. 5, no. 4, p. 316.
Fecka, I., Cisowski, W. Multiple gradient development TLC in analysis of complex phenolic acids from Lycopus europaeus L. . Chromatographia, 1999, vol. 49, no. 5-6, p. 256-260. DOI
Hamann, I., Seidlova-Wuttke, D., Wuttke, W., K�hrle, J. Effects of isoflavonoids and other plant-derived compounds on the hypothalamus-pituitary-thyroid hormone axis. Maturitas, 2006, vol. 55, no. SUPPL. 1, p. S14-S25. DOI

Boundary

A constituent measurement is a fact about material at a stated preparation, not a statement about what that material does in a person. An adverse-effect or genotoxicity record is an observation reported in a source, most often in an animal or laboratory model. Neither is a Metatron Health conclusion about causality, human risk or benefit, and the absence of a record is not proof that a preparation is safe. Nothing here is diagnosis, prescribing or individual medical care.

Continue

Independent literature